Editorial & Opinion
A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma.
| العنوان: | A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma. |
|---|---|
| المؤلفون: | DeStefano VM; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA., Wada M; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA., Pinz KG; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA., Assi R; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Zhang H; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China., Wang W; Department of Advanced Diagnostic and Clinical Medicine, Zhongshan People's Hospital, Zhongshan, People's Republic of China., Zhang W; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China., Shah D; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA., Ma Y; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA., Salman H; Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, Indiana, USA. |
| المصدر: | Clinical and translational medicine [Clin Transl Med] 2024 Jul; Vol. 14 (7), pp. e1743. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2020- : [Hoboken, NJ] : Wiley Original Publication: Heidelberg : Springer-Verlag |
| مواضيع طبية MeSH: | Antigens, CD20*/immunology , Lymphoma, B-Cell*/immunology , Lymphoma, B-Cell*/drug therapy , Antigens, CD19*/immunology , Receptors, Chimeric Antigen*/immunology, Humans ; Leukemia, B-Cell/immunology |
| References: | Front Immunol. 2019 Nov 12;10:2664. (PMID: 31798590) N Engl J Med. 2016 Aug 25;375(8):740-53. (PMID: 27292104) Nat Rev Drug Discov. 2022 Jun;21(6):411-412. (PMID: 35246638) Exp Hematol Oncol. 2012 Nov 29;1(1):36. (PMID: 23210908) Arthritis Res Ther. 2013;15 Suppl 1:S3. (PMID: 23566754) Ann Oncol. 2018 May 1;29(5):1086-1089. (PMID: 29554220) Nat Rev Clin Oncol. 2020 Mar;17(3):147-167. (PMID: 31848460) Oncotarget. 2017 Nov 22;8(68):112783-112796. (PMID: 29348865) Cancer Discov. 2015 Dec;5(12):1282-95. (PMID: 26516065) N Engl J Med. 2021 Feb 18;384(7):673-674. (PMID: 33596362) |
| المشرفين على المادة: | 0 (Antigens, CD20) 0 (Antigens, CD19) 0 (Receptors, Chimeric Antigen) 0 (CD19 molecule, human) |
| تواريخ الأحداث: | Date Created: 20240723 Date Completed: 20240723 Latest Revision: 20240725 |
| رمز التحديث: | 20240726 |
| مُعرف محوري في PubMed: | PMC11263732 |
| DOI: | 10.1002/ctm2.1743 |
| PMID: | 39039937 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2001-1326 |
|---|---|
| DOI: | 10.1002/ctm2.1743 |